Nonpharmacologic options for treating irritable bowel syndrome

JAAPA : Official Journal of the American Academy of Physician Assistants
Emelia KayEllen D Mandel

Abstract

Irritable bowel syndrome (IBS) is a chronic functional disorder with no organic cause. Risk factors are multifactorial and treatment typically consists of antimotility or stimulant laxatives and antidepressants. This article reviews several newer areas of interest: probiotics, fecal microbiota transplant, a low FODMAP diet, and cognitive behavioral therapy.

References

Jan 14, 2005·European Journal of Gastroenterology & Hepatology·Heiko Santelmann, John McLaren Howard
Jun 14, 2005·Alimentary Pharmacology & Therapeutics·P R Gibson, S J Shepherd
Mar 14, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Gregory L AustinDouglas A Drossman
Aug 30, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Uri LadabaumTheodore R Levin
Mar 1, 2012·World Journal of Gastroenterology : WJG·Teodora Surdea-BlagaDan L Dumitrascu
Mar 15, 2014·World Journal of Gastroenterology : WJG·Uday C Ghoshal, Deepakshi Srivastava
Apr 20, 2014·World Journal of Gastroenterology : WJG·Jennifer K BeattyAndre G Buret
Jun 3, 2014·Gut Pathogens·Tamalee RobertsJohn Ellis
Sep 19, 2014·World Journal of Gastroenterology : WJG·Rosa L S Soares
Nov 27, 2014·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·D M PinnL J Brandt
Feb 24, 2016·World Journal of Gastroenterology : WJG·Eleonora DistruttiStefano Fiorucci
Apr 22, 2016·World Journal of Gastroenterology : WJG·Louise MaagaardPia Munkholm
May 10, 2016·Nature Reviews. Disease Primers·Paul EnckRobin C Spiller
Oct 19, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Laurie Keefer
Jul 20, 2016·Journal of Neurogastroenterology and Motility·Mohammad H FarzaeiRoja Rahimi
Oct 12, 2016·The American Journal of Gastroenterology·Shanti L EswaranKenya Jackson
Jan 20, 2017·Clinical and Translational Gastroenterology·Sarah Ballou, Laurie Keefer
Feb 18, 2017·Gastroenterology Research and Practice·Hanna Edebol-CarlmanRobert J Brummer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.